Highlights

  • dorsaVi shares remained unchanged at AUD 0.035 on 28 April 2026, despite the release of a positive update.
  • Company expands strategy into exoskeleton and human-robot collaboration markets.
  • Exoskeleton market projected to exceed ~USD 2 billion by 2033.
  • Broader robotics opportunity estimated to exceed USD 100 billion by 2030.
  • Neuromorphic and in-memory processing IP Acquisition completed.
  • Engagement discussions initiated with Israel-based partners and Venture Capital firms.
  • Technology leverages existing sensor platform and RRAM semiconductor program

DorsaVi Ltd (ASX:DVL) shares traded flat at AUD 0.035 during the session on 28 April 2026, despite the company releasing an update outlining an expansion of its robotics intelligence strategy into next-generation exoskeleton applications. While the stock showed no immediate price movement on the day, it remains 250% up over the past year, reflecting broader investor interest in the company’s evolving technology platform.

The update introduces a new strategic application pathway for dorsaVi’s existing capabilities, particularly its wearable motion sensors and neuromorphic semiconductor program, positioning the company within emerging human-robot collaboration markets.

Company Overview

dorsaVi Ltd is focused on enabling real-time, AI-driven decision-making at the point of sensing, often referred to as “ultra-edge intelligence.” Its core technology includes wearable sensors capable of capturing detailed human movement data outside laboratory environments, supporting applications across clinical, workplace safety, and performance monitoring settings.

The company is also advancing its capabilities in neuromorphic computing and resistive random-access memory (RRAM), aiming to deliver low-power, edge-based processing solutions that operate without reliance on cloud infrastructure. These technologies underpin its broader ambition to participate in next-generation robotics and human-machine interaction systems.

Expansion into Exoskeleton Applications

The company announced that it has identified powered exoskeleton systems as a strategic application area for its existing technology stack. These systems, which enhance human strength, endurance, and mobility, are increasingly being deployed across defence, industrial, healthcare, and aged care sectors.

According to the update, exoskeletons represent an initial entry point into the broader human-robot collaboration ecosystem. The company is currently evaluating commercial opportunities across three primary areas: exoskeleton intelligence layers, human-in-the-loop robotic control, and fatigue-aware robotics.

Importantly, the company clarified that this strategic direction builds directly on its existing capabilities rather than representing a shift in core focus. The same sensor technology and semiconductor development program that support its current operations are being extended into this new application domain.

Sensor Technology as the Intelligence Layer

A central element of the company’s strategy is its proprietary wearable motion sensing technology, which captures high-resolution biomechanical data in real time. Within exoskeleton systems, these sensors function as the intelligence layer, providing continuous insight into user movement, force distribution, and physical condition.

This capability enables exoskeleton systems to respond dynamically to human motion, supporting adaptive control and safety monitoring. The company noted that its sensors can detect conditions such as overextension, uneven loading, and fatigue, which can then be used to adjust system behaviour accordingly.

The integration of such sensor-driven intelligence is positioned as addressing a key gap in current exoskeleton systems, where real-time interpretation of human movement remains a technical challenge.

Neuromorphic Computing Enables Edge Processing

In addition to sensing capabilities, the company’s RRAM-based neuromorphic semiconductor program plays a significant role in its exoskeleton strategy. Neuromorphic computing is designed to mimic the structure and function of the human brain, enabling efficient, parallel data processing.

For exoskeleton applications, this approach allows for real-time data processing directly on the device, eliminating the need for cloud-based computation. This is particularly relevant for wearable systems, where low latency and energy efficiency are critical.

The company highlighted several advantages of its neuromorphic approach, including ultra-low power consumption, continuous learning capabilities, and the ability to process sensor data locally. These features are aligned with the operational requirements of battery-powered exoskeleton systems.

Three Key Application Pathways

dorsaVi outlined three primary pathways for applying its technology within the exoskeleton market.

The first involves embedding its sensors within exoskeleton systems to provide real-time movement intelligence, supporting applications in rehabilitation, aged care, and industrial environments.

The second pathway focuses on human-in-the-loop robotic control, where sensor data and neuromorphic processing are combined to create closed-loop systems. In these systems, human input directly guides robotic movement, with safety boundaries integrated into the control framework.

The third pathway centres on fatigue-aware robotics, where motion analytics are used to detect patterns associated with fatigue or injury risk. This information can be used to automatically adjust assistance levels, supporting workplace safety and compliance requirements.

Market Opportunity and Industry Context

The company’s update highlights the scale of the opportunity it is targeting. The global exoskeleton market was valued at approximately USD 590 million in 2025 and is projected to grow to around USD 2 billion by 2033.

Beyond exoskeletons, the company identified a broader addressable market exceeding USD 100 billion by 2030, encompassing collaborative robots, surgical robotics, autonomous mobile systems, and defence-related applications.

Each of these sectors relies on safe and efficient human-machine interaction, an area where the company’s sensor and neuromorphic technologies are positioned to contribute.

Building on Existing Capabilities

A key theme of the update is that the company’s expansion into robotics leverages its current technology base. Its wearable sensors, biomechanical analytics, and data ecosystem are already capable of capturing and analysing human movement.

These capabilities are being extended into robotics applications, where they can provide real-time feedback and enable adaptive system behaviour. Similarly, the company’s neuromorphic semiconductor program is being developed to support edge-based processing across these use cases.

This approach allows the company to pursue new market opportunities without requiring entirely new foundational technologies, aligning with its focus on Capital efficiency.

Completion of Neuromorphic IP Acquisition

The company also confirmed the completion of its previously announced Acquisition of neuromorphic and in-memory processing intellectual property. This IP strengthens its capabilities in processing-in-memory and memristor-based logic design.

These technologies are considered central to the company’s “intelligence at the ultra-edge” strategy, enabling efficient data processing directly at the source.

Following the Acquisition, the company has initiated discussions with potential commercial partners and Venture Capital firms based in Israel. The region’s established ecosystem in semiconductor design and artificial intelligence hardware is seen as supportive for advancing development and commercialisation efforts.

Broader Robotics Applications Under Evaluation

While exoskeletons represent the initial focus, the company indicated that its technology stack has broader applicability across multiple robotics segments.

These include collaborative robots used in industrial environments, surgical and rehabilitation robotics in healthcare, autonomous mobile robots in logistics, and defence systems involving human-robot coordination.

The company noted that it is actively assessing opportunities to expand into these adjacent markets and expects to provide further updates on its broader robotics strategy.

What This Means for Investors?

The latest update from dorsaVi outlines an expansion of its technology platform into exoskeleton and human-robot collaboration markets, leveraging its existing sensor and neuromorphic computing capabilities.

The identified market opportunities, including a projected USD 2 billion exoskeleton market and a broader robotics ecosystem exceeding USD 100 billion, provide context for the company’s strategic direction.

Despite these developments, the company’s share price remained unchanged on the day of the announcement, suggesting that the market may be awaiting further clarity on execution, commercial partnerships, or Revenue pathways.

With the stock already up significantly over the past year, investor focus may now be shifting toward how the company translates its technology into commercial outcomes within these emerging sectors.